Medicine and Dentistry
Asthma
100%
Patient
74%
Severe Asthma
63%
Therapeutic Procedure
38%
Corticosteroid
38%
Eosinophilic
37%
Eosinophil
33%
Biological Product
27%
Benralizumab
26%
Combination Therapy
20%
Disease
19%
Biological Therapy
17%
Adult
15%
Lung
13%
Symptom
13%
Consensus
12%
Phenotype
11%
Rhinovirus Infection
11%
Blood
11%
Interferon
11%
Diagnosis
10%
Rhinovirus
10%
Primary Health Care
9%
Mepolizumab
9%
Health
9%
Inpatient
8%
Steroid
8%
Antivirus Agent
8%
Virus
8%
Disease
8%
Placebo
7%
Assessment
7%
Serositis
7%
Reslizumab
6%
Pathogenesis
6%
Disease Severity
6%
Quality of Life
6%
Virus Infection
6%
Biological Marker
5%
Dupilumab
5%
Respiratory Disease
5%
Wheeze
5%
Patient Referral
5%
Association
5%
Etiology
5%
Granulomatosis with Polyangiitis
5%
Hand-Schüller-Christian Disease
5%
Serum
5%
Immunology and Microbiology
Asthma
51%
Rhinovirus
37%
Asthma Exacerbation
36%
Severe Asthma
20%
Biological Product
17%
Interferon Type I
17%
Inflammation
13%
Viral Disease
13%
Eosinophil Granulocyte
11%
Virus
9%
Health
9%
Allergic Inflammation
8%
Immune Response
7%
Electric Potential
7%
Regulatory Mechanism
7%
Normal Human
6%
Cytokine
6%
Lung
6%
Cells
6%
Interleukin 15
5%
Respiratory Virus
5%
Interleukin 13
5%
Allergic Asthma
5%
CCL17
5%
Macrophage
5%
Dupilumab
5%
Mouse
5%
Liquid
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
58%
Corticosteroid
20%
Biological Product
16%
Benralizumab
16%
Mepolizumab
11%
Diseases
8%
Respiratory Tract Disease
6%
Pathogenesis
5%
Clinical Trial
5%